Webinar: Treating Patients, Testing Patients: A Hospital at the Forefront of COVID-19 Treatments (Dr. Ravit Barkama)

30/11/2020 - 19:00 - 18:00Add To Calendar 2020-11-30 18:00:00 2020-11-30 19:00:00 Webinar: Treating Patients, Testing Patients: A Hospital at the Forefront of COVID-19 Treatments (Dr. Ravit Barkama) Dr. Ravit Barkama is assistant vice president of clinical development at Holy Name Medical Center in Tenafly, New Jersey, where she manages its Institute for Clinical Research, responsible for bringing cutting-edge technologies and effective new drugs to patients in need before they are approved for commercial use. Her efforts and leadership led to Holy name medical Centre to be the first in the US to use Pluristem cell-based therapy in the fight against COVID-19. Dr. Barkama creates strategic collaborations with physician groups, local care providers through the care continuum, community partners, and other hospitals to achieve better care at lower cost for individuals and populations. Before joining Holy Name, she led the cardiology research activities at Columbia University Medical Center and served for more than a decade as a medical director in the Israeli medical-device industry, where she focused on identifying new technologies and clinical research. Read more here. Register here. Zoom הפקולטה לרפואה biu.medicine@mail.biu.ac.il Asia/Jerusalem public

Location

Zoom

Dr. Ravit Barkama is assistant vice president of clinical development at Holy Name Medical Center in Tenafly, New Jersey, where she manages its Institute for Clinical Research, responsible for bringing cutting-edge technologies and effective new drugs to patients in need before they are approved for commercial use. Her efforts and leadership led to Holy name medical Centre to be the first in the US to use Pluristem cell-based therapy in the fight against COVID-19.

Dr. Barkama creates strategic collaborations with physician groups, local care providers through the care continuum, community partners, and other hospitals to achieve better care at lower cost for individuals and populations. Before joining Holy Name, she led the cardiology research activities at Columbia University Medical Center and served for more than a decade as a medical director in the Israeli medical-device industry, where she focused on identifying new technologies and clinical research.